Masimo's ISpO2 Rx Pulse Oximeter Gets CE Mark For Use In Mobile Devices

(RTTNews) - Masimo Corp. (MASI) Thursday said its ISpO2 Rx Pulse Oximeter for Android and iOS devices received CE Mark clearance for medical use in select countries.

As a result, clinicians would be able to use Masimo SET Measure-through Motion and Low Perfusion Pulse Oximetry on their smart phones and tablets.

iSpO2 Rx provides accurate spot-check and short-term assessment of oxygen saturation, pulse rate and perfusion index. Currently it is available outside the U.S. It uses the Masimo SET Measure-through Motion and Low Perfusion pulse oximetry technology proven by more than 100 independent and objective studies and used on more than 100 million patients a year in hospitals worldwide.

iSpO2 Rx for select Android devices and iPad, iPhone, and iPod touch, also features a downloadable and upgradeable iSpO2 Rx App, ensuring clinicians to have access to the latest mobile medical technologies at their fingertips.